Lenalidomide performs anti-myeloma and anti-inflammatory function through acting on myeloid DCs

Kazuyo Yamamoto

Presentation information

Oral Session

Oral Session 1-15D Basic and clinical in hematological diseases/Others

Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.15 (Osaka International Convention Center, 7F 701-2)

Chair: Yasuo Miura (Department of Trasfusion Medcine & Cell Therapy Kyoto University Hospital, Japan)

[OS1-15D-5] Lenalidomide performs anti-myeloma and anti-inflammatory function through acting on myeloid DCs

Kazuyo Yamamoto¹, Toshio Kitawaki¹, Naoshi Sugimoto³, Yumi Kawase¹, Yuki Sueki¹, Haruyuki Fujita¹, Akifumi Takaori-Kondo¹, Norimitsu Kadowaki² (1.Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2.Hematology, Rheumatology and Respiratory Medicine, Kagawa University, Kagawa, Japan, 3.CiRA, Kyoto University, Kyoto, Japan)

Abstract password authentication.
Password is written on a program and abstract book.